| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.0064 | 0.8 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.032 | 0.8 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.0068 | 0.8 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.034 | 0.8 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.032 | 0.8 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |